The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...
The agreement announced Wednesday includes sweeping changes to the Cigna PBM’s business practices, including no longer ...
A Settlement, Not a Sigh of Relief: What the FTC’s Express Scripts Deal Signals for Enforcement Risk
The FTC’s newly announced settlement with Express Scripts marks a pivotal moment in the government’s campaign against pharmacy benefit manager pricing practices—and it should be read as more than a ...
Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated ...
According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...
The settlement comes after the FTC in September 2024 brought action against three prescription drug benefit managers, including Express Scripts, alleging the companies were artificially inflating the ...
Senators Hawley and Warren want to break up vertically integrated healthcare conglomerates. History shows, however, how hard a task this will be to accomplish.
Express Scripts’ FTC settlement over insulin pricing is expected to save consumers $7B over 10 years. Read more here.
Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...
The FTC settled a lawsuit against Express Scripts over allegations that the company artificially inflated the price of insulin and impeded access to treatment.
The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results